APA (7th ed.) Citation

Y, W., B, L., Y, C., Z, W., B, H., Y, X., . . . Q, B. (2026). Prognostic significance of atrial functional mitral regurgitation in patients with HFpEF and end-stage renal disease. Frontiers in cardiovascular medicine, 13, 1788372. https://doi.org/10.3389/fcvm.2026.1788372

Chicago Style (17th ed.) Citation

Y, Wang, et al. "Prognostic Significance of Atrial Functional Mitral Regurgitation in Patients with HFpEF and End-stage Renal Disease." Frontiers in Cardiovascular Medicine 13 (2026): 1788372. https://doi.org/10.3389/fcvm.2026.1788372.

MLA (9th ed.) Citation

Y, Wang, et al. "Prognostic Significance of Atrial Functional Mitral Regurgitation in Patients with HFpEF and End-stage Renal Disease." Frontiers in Cardiovascular Medicine, vol. 13, 2026, p. 1788372, https://doi.org/10.3389/fcvm.2026.1788372.